View all reports
BridgeBio Pharma, Inc. (BBIO) stock forecast and price target
Find the latest BridgeBio Pharma, Inc. BBIO analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
Date Range
investment rating
report type
sector
industry
provider
BBIOBridgeBio Pharma, Inc.25.03 -0.43 (-1.69%)
At close: 08:00PM
Recommendation Rating
1.9
Analyst Price Targets (13)
Current 25.03
Average 49.00
Low 33.00
High 70.00
Related Research Reports1-3 of 3 results
| Report Name | Symbols | Sector | Provider | Date | |
|---|---|---|---|---|---|
| NTG,LSEA,AZEK,BLFY,OXSQ,TYG,VRAR,JRVR,NOTV,SNSE,ENTX,ATGE,TTP,TEAF,COMM,BBIO,GLSI,NDP,FLNC,RSVR,NVCT | Communication Services,Utilities,Financial Services,Technology,Real Estate,Healthcare,Consumer Defensive,Industrials | Argus | Mar 29, 2022 | Upgrade to begin downloading full reports | |
| LESL,RBC,SF,BBIO,MPWR,BMBL,MKL | Financial Services,Technology,Healthcare,Industrials,Consumer Cyclical | Argus | Feb 22, 2021 | Upgrade to begin downloading full reports | |
| SF,PACB,BBIO,SEIC,LPLA,SIVBQ,SNAP,NUS,CFR | Communication Services,Financial Services,Healthcare,Consumer Defensive | Argus | Feb 19, 2021 | Upgrade to begin downloading full reports |